Vai al contenuto

Interazioni tra farmaci

Fingolimod + Liposomal doxorubicin

Gravità: Maggiore

Fingolimod and Liposomal doxorubicin: major interaction.

Ultimo aggiornamento

Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.

Il contenuto clinico di questa pagina è disponibile solo in inglese.

Sintesi

Both agents suppress immune function, so combined use may increase the risk of serious infections. Fingolimod lowers circulating lymphocytes, adding to chemotherapy-related myelosuppression.

Cosa significa questa interazione in parole semplici

Fingolimod and Liposomal doxorubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Fingolimod belongs to Central Nervous System; Liposomal doxorubicin belongs to Oncology.

Livello di evidenza: Low

Perché avviene

Additive immunosuppression from lymphocyte sequestration by fingolimod and myelosuppression by doxorubicin.

Cosa fare

Avoid concurrent use where possible and monitor blood counts and signs of infection. Consider interrupting fingolimod during chemotherapy.

Cosa chiedere al farmacista

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Per gli utenti Pro+

Sblocca la pagina completa

Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Fingolimod e Liposomal doxorubicin, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.

Domande frequenti

Can I take Fingolimod with Liposomal doxorubicin?

MediHelp rates the interaction as major. Fingolimod and Liposomal doxorubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both agents suppress immune function, so combined use may increase the risk of serious infections. Fingolimod lowers circulating lymphocytes, adding to chemotherapy-related myelosuppression.

How serious is the interaction between Fingolimod and Liposomal doxorubicin?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use where possible and monitor blood counts and signs of infection. Consider interrupting fingolimod during chemotherapy.

What other medicines interact with Liposomal doxorubicin?

MediHelp also lists interactions of Liposomal doxorubicin with, for example, Dengue vaccine, Belatacept, Cyclosporine. The full list is on the Liposomal doxorubicin page.

Monografie complete, posologie e verifica delle interazioni nell'app MediHelp

Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.

Sfoglia dalla A alla Z · Interazioni tra farmaci

Scarica l'app Accedi